Expression of PD-L1 in pleural effusion of advanced lung adenocarcinoma and its relationship with DNA ploidy.
1/5 보강
[OBJECTIVE] Programmed death receptor-1 (PD-1) negatively regulates antigen receptor signaling upon binding to its ligands, programmed death-ligand 1 or 2 (PD-L1/2), enabling tumor cells to evade immu
APA
Wu J, Huang L, et al. (2025). Expression of PD-L1 in pleural effusion of advanced lung adenocarcinoma and its relationship with DNA ploidy.. Pakistan journal of medical sciences, 41(11), 3177-3180. https://doi.org/10.12669/pjms.41.11.11655
MLA
Wu J, et al.. "Expression of PD-L1 in pleural effusion of advanced lung adenocarcinoma and its relationship with DNA ploidy.." Pakistan journal of medical sciences, vol. 41, no. 11, 2025, pp. 3177-3180.
PMID
41394357 ↗
Abstract 한글 요약
[OBJECTIVE] Programmed death receptor-1 (PD-1) negatively regulates antigen receptor signaling upon binding to its ligands, programmed death-ligand 1 or 2 (PD-L1/2), enabling tumor cells to evade immune surveillance. This study aimed to investigate the expression of PD-L1 in tumor cells present in pleural effusion (PE) from lung adenocarcinoma (LUAD) with metastasis and its relationship with DNA ploidy. Furthermore, it sought to assess whether high PD-L1 expression enhances tumor cell proliferation and invasiveness.
[METHODOLOGY] This was a retrospective study. PE specimens were collected from patients diagnosed with stage IV LUAD, meeting the malignant tumor UICC (Union for International Cancer Control) TNM staging system, at the Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital between July 2021 to December 2023. The expression of PD-L1 in LUAD cells in PE was detected using immunocytochemistry, and the invasiveness of tumor cells with varying PD-L1 expression levels was evaluated through DNA quantitative analysis.
[RESULTS] The positive expression rate of PD-L1 in PE from advanced LUAD was 60.22%. Variations in PD-L1 expression were associated with the mean DNA index values exceeding 2.5 among the top 20 tumor cells analyzed.
[CONCLUSION] Compared with the non-expression group, the low-expression PD-L1 group demonstrated greater tumor cell invasiveness.
[METHODOLOGY] This was a retrospective study. PE specimens were collected from patients diagnosed with stage IV LUAD, meeting the malignant tumor UICC (Union for International Cancer Control) TNM staging system, at the Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital between July 2021 to December 2023. The expression of PD-L1 in LUAD cells in PE was detected using immunocytochemistry, and the invasiveness of tumor cells with varying PD-L1 expression levels was evaluated through DNA quantitative analysis.
[RESULTS] The positive expression rate of PD-L1 in PE from advanced LUAD was 60.22%. Variations in PD-L1 expression were associated with the mean DNA index values exceeding 2.5 among the top 20 tumor cells analyzed.
[CONCLUSION] Compared with the non-expression group, the low-expression PD-L1 group demonstrated greater tumor cell invasiveness.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.
- Vitamin B6 preserves the stemness-like phenotypes and antitumor ability of CD8 T cells.
- Advances in light-controllable PROTACs: Design strategies, therapeutic applications and current challenges.
- Efficacy of nerve blocks for postoperative analgesia in lung cancer: A meta-analysis of randomized clinical trials.
- [Clinical characteristics of 20 lung adenocarcinoma patients misdiagnosed as interstitial pneumonia].
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Combining network pharmacology and experimental validation to study the action and mechanism of brusatol against lung adenocarcinoma.
- Acquired L858R mutation following -TKI resistance in lung adenocarcinoma: a case report.
- Efficacy of first-line immunochemotherapy across KRAS mutation subtypes in advanced lung adenocarcinoma.
- Multi-omics analysis and experiments validate the tumor-suppressive role of mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and its impact on the immune microenvironment.
- Prediction of high-risk factor in early-stage lung cancer: micropapillary adenocarcinoma.
- Integrated bulk and single-cell transcriptomics with experimental validation to identify calmodulin-related prognostic genes in lung adenocarcinoma.